These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2861774)

  • 1. Memory function and brain biochemistry in normal aging and in senile dementia.
    Winblad B; Hardy J; Bäckman L; Nilsson LG
    Ann N Y Acad Sci; 1985; 444():255-68. PubMed ID: 2861774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical changes in the cholinergic system of the ageing brain and in senile dementia.
    Bowen DM; Davison AN
    Psychol Med; 1980 May; 10(2):315-9. PubMed ID: 6104344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.
    Davies P
    Brain Res; 1979 Aug; 171(2):319-27. PubMed ID: 37989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).
    Gottfries CG; Adolfsson R; Aquilonius SM; Carlsson A; Eckernäs SA; Nordberg A; Oreland L; Svennerholm L; Wiberg A; Winblad B
    Neurobiol Aging; 1983; 4(4):261-71. PubMed ID: 6200784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitters in dementia.
    Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
    Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.
    Henke H; Lang W
    Brain Res; 1983 May; 267(2):281-91. PubMed ID: 6871677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.
    Perry EK; Tomlinson BE; Blessed G; Bergmann K; Gibson PH; Perry RH
    Br Med J; 1978 Nov; 2(6150):1457-9. PubMed ID: 719462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens.
    Sorbi S; Antuono P; Amaducci L
    Ital J Neurol Sci; 1980 Mar; 1(2):75-83. PubMed ID: 7040296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type.
    Danielsson E; Eckernäs SA; Westlind-Danielsson A; Nordström O; Bartfai T; Gottfries CG; Wallin A
    Neurobiol Aging; 1988; 9(2):153-62. PubMed ID: 2897639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.
    Bowen DM; Smith CB; White P; Davison AN
    Brain; 1976 Sep; 99(3):459-96. PubMed ID: 11871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.
    Quirion R; Martel JC; Robitaille Y; Etienne P; Wood P; Nair NP; Gauthier S
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):503-10. PubMed ID: 2878714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
    Davies P; Katzman R; Terry RD
    Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment.
    Jonsson G; Sachs C
    Med Biol; 1976 Aug; 54(4):286-97. PubMed ID: 8670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relations between specific neurochemical systems and memory: problems posed by dementia of the Alzheimer type].
    Lussier I; Stip E
    J Psychiatry Neurosci; 1995 Jan; 20(1):49-66. PubMed ID: 7865501
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease.
    Reinikainen KJ; Paljärvi L; Halonen T; Malminen O; Kosma VM; Laakso M; Riekkinen PJ
    Neurobiol Aging; 1988; 9(3):245-52. PubMed ID: 3398991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenergic and cholinergic systems in senile dementia of Alzheimer type.
    Perry EK; Tomlinson BE; Blessed G; Perry RH; Cross AJ; Crow TT
    Lancet; 1981 Jul; 2(8238):149. PubMed ID: 6113507
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine-beta-hydroxylase activities in serum and cerebrospinal fluid of aged and demented patients.
    Miyata S; Nagata H; Yamao S; Nakamura S; Kameyama M
    J Neurol Sci; 1984 Mar; 63(3):403-9. PubMed ID: 6726279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggression and central neurotransmitters.
    Pradhan SN
    Int Rev Neurobiol; 1975; 18():213-62. PubMed ID: 1353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.